Concepedia

Publication | Closed Access

The inhibitory in-vitro effect of high-dose levosimendan on platelet function may be mediated through its action as a phosphodiesterase inhibitor

DOI

11

Citations

0

References

2012

Year

Konstanze Plaschke, Franziska Bent, Claudia Rosenhagen, Sören Wagner, Stefan Hofer, Jürgen Kopitz
Coronary Artery Disease

Abstract

Levosimendan has no significant effect as a phosphodiesterase III inhibitor on in-vitro platelet aggregation in clinically relevant doses.